GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cinclus Pharma Holding AB (OSTO:CINPHA) » Definitions » Unearned Income

Cinclus Pharma Holding AB (OSTO:CINPHA) Unearned Income


View and export this data going back to 2024. Start your Free Trial

What is Cinclus Pharma Holding AB Unearned Income?

Unearned Income only applies to banks.


Cinclus Pharma Holding AB Business Description

Traded in Other Exchanges
Address
Kungsbron 1, Stockholm, SWE, SE-111 22
Cinclus Pharma Holding AB is a clinical stage pharmaceutical company developing a drug for the treatment of erosive gastroesophageal reflux diseases, and a dual therapy treatment with an antibiotic targeting Helicobacter pylori which is a bacteria that occurs in the gastric and duodenal mucosa. The Company's main target population is patients suffering from severe eGERD, where there is a lack of satisfactory treatment options.